Clinical Trial Update: Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg [Phase 3]

View source ↗

Summary

Phase 3 randomized open-label trial comparing corticosteroids with intravenous immunoglobulin for demyelinating polyneuropathy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demyelinating Polyneuropathy

Drugs mentioned

• Corticosteroids (corticosteroids)
• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Demyelinating Polyneuropathy | Phase 3 | Status: COMPLETED